- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Prosolia Inc. restructures top management
October 16, 2010
IBJ StaffThe company, which develops mass spectrometry devices used in the life sciences and industrial chemistry, has a new CEO, among
other changes.
MoreBiomet sales rise, but slower than expected
October 13, 2010
Associated PressBiomet's quarterly results are considered an indicator on the state of the orthopedic device industry because it reports results
before most of its competitors.
MoreLilly's Erbitux shows mixed results in cancer studies
October 11, 2010
Bloomberg NewsIn combination with chemotherapy, the drug failed to help colon-cancer patients in a European trial but did delay the spread
of breast cancer in some patients with a certain type of aggressive tumor.
MoreBeckman Coulter plans $18.2M expansion, 100 new jobs
October 8, 2010
IBJ StaffCalifornia-based life sciences firm Beckman Coulter Inc. is planning its third local expansion since 2007, investing $18.2
million in its Indianapolis operation and adding as many as 95 jobs here in the next three years.
MoreCommunity moves to integrate doctors
September 15, 2010
J.K. Wall
Community Health now has about 550 physicians, either on its payroll
or committed through integration contracts, who have some of their pay hinge on measures of quality and communication. CEO
Bryan Mills says the hospital system is looking to add even more.
Dow Agro acquires Colorado seed company
September 2, 2010
IBJ StaffGrand Valley Hybrids has been growing and conditioning hybrid seed corn in the West since 1946.
MoreAppeals court ruling upholds Lilly's Evista patents
September 1, 2010
Bloomberg NewsEli Lilly and Co. won a court ruling Wednesday that blocks plans by Teva Pharmaceutical Industries Ltd. to sell a generic
version of the Evista osteoporosis treatment before March 2014.
MoreLocal economic espionage case full of intrigue
September 1, 2010
Cory SchoutenThe government's allegations read like a spy novel: Dr. Ke-xue "John" Huang lands a job at Indianapolis-based
Dow AgroSciences and over five years works himself into a position of trust, with access to trade secrets and processes the
company has invested $300 million to develop.
MoreEx-Dow Agro scientist's espionage indictment unsealed
August 31, 2010
IBJ StaffA federal indictment unsealed Tuesday in Indianapolis charged 45-year-old Ke-xue "John" Huang
with theft and attempted
theft of trade secrets to benefit a foreign government.
MoreEndocyte's $86M IPO plan a boon for Indiana, investors
August 28, 2010
Greg AndrewsVenture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
MoreCancer drug developer Endocyte files for IPO
August 18, 2010
Scott OlsonThe company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet
to be determined.
MoreBiomet investing $26M to expand, create nearly 280 jobs
August 13, 2010
IBJ StaffOrthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by
the end of 2012.
MoreIndiana universities offer cash incentives for technology transfer
August 7, 2010
IBJ StaffThe Indiana Clinical and Translational Sciences Institute awarded $750,000 to 10 teams of researchers.
MoreDow Agro boosts sales, profit in second quarter
August 3, 2010
IBJ Staff and Bloomberg NewsIndianapolis-based Dow AgroSciences improved sales and profit in its second quarter thanks to higher volumes and lower costs,
the company said Tuesday morning.
MoreIndiana life sciences companies capture more venture capital money in first half of 2010
July 31, 2010
IBJ StaffVenture dollars for Hoosier companies are still few, but the flow of deals is picking up.
MoreLilly's second-quarter profits surge 16 percent
July 22, 2010
J.K. WallIndianapolis-based drugmaker Eli Lilly and Co. recorded profits of $1.3 billion, or $1.22 per share, during the three months
ended June 30,
even after paying $27 million in severance to laid off employees.
MoreNew rules raise stakes for Lilly drug
July 21, 2010
J.K. WallDrugmakers testing experimental Alzheimer’s medicines—including Eli Lilly and Co.—got good news last week
when the National Institute on Aging and the Alzheimer’s Association proposed new guidelines to make earlier diagnoses
of the disease.
MoreLilly's Lechleiter: No change in plans
July 7, 2010
J.K. WallThe global financial press keeps asking John Lechleiter for his end-game strategy to survive Eli Lilly and Co.'s nightmarish
patent challenges. And, like a broken record, the Lilly CEO keeps giving the same answer: pipeline, pipeline, pipeline—no
mega-merger.
MoreMarcadia enlists Lilly to help develop new diabetes drug
June 28, 2010
J.K. WallThe two companies will jointly develop a short-acting glucagon drug, which they hope proves more convenient than Lilly’s
current Glucagon for patients with severe hypoglycemia.
MoreQ&A
June 23, 2010
J.K. WallDavid Stocum is the director of the Center for Regenerative Biology and Medicine at the IUPUI School of Science.
He and his team are studying how amphibians regenerate parts of their bodies to see if there are ways to induce humans to
regenerate tissue that is lost or damaged. The center has about 20 researchers and funding of about $14 million to fuel its
quest.
MoreIndiana's biggest private companies majored in the basics in 2009
June 19, 2010
Martha P. AllanHealth care, plastics, other fundamental consumer needs kept some companies on upswings.
MorePromising ethanol yeast nears market launch
June 19, 2010
Chris O'MalleyA firm that may have developed a breakthrough yeast for ethanol production has landed new investment and high-octane board
members. Two-year-old Xylogenics Inc. also says it plans to license its first bioengineered yeast later this year.
MoreAIT Labs moving headquarters, adding 160 jobs
June 17, 2010
Scott OlsonThe Indianapolis-based forensics, clinical and pharmaceutical testing firm, led by CEO Michael Evans, plans to invest $74
million to acquire and equip
an existing 90,000-square-foot building in Woodland Corporate Park near West 79th Street and Interstate 465.
MoreUPDATE: Commission approves City Market funding
June 16, 2010
Scott OlsonThe Metropolitan Development Commission voted Wednesday afternoon to release nearly $4 million to
improve
the historic building in downtown Indianapolis.
MoreIndiana Seed Fund nearing end of $6 million stash
June 5, 2010
Chris O'MalleyHaving invested in 10 companies since 2005 and with its $6 million pot of money running low, the Indiana Seed Fund is nearing
a crossroads.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Can IBJ please stop referring to this property as "Kessler Mansion"? What a ridiculous title for the biggest, bloated, blight in our city. It's not a mansion. At best, it's an ideal site to shoot low-budget porn. Ahhh! Another business use!
Its stories like these that prove that a Ball State diploma is worth less than the paper that its printed on. A real institution of higher learning would have taken care of this long ago. No way should this crap be taught in a SCIENCE class.
It is such a shame that King Ballard has made Indianapolis into Chicago south with all of the rampant corruption.
How many of these 1,259 bills were actually heard and voted on on the floor vs how many were shot down in committee?
When a an arrogant young guy with essentially no experience and no qualifications for the job, was dropped into an Administrator position out of nowhere by his "mentor" in the Mayor's office things seemed fishy. Sometimes things are what they seem.